Buscar

01/04/2026 Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021)
Cuyàs, B, Alvarado-Tapias, E, Tan, EH, Golozar, A, Duarte-Salles, T, Delmestri, A, Argemi, J, Man, WY, Burn, E, Guarner-Argente, C, Alhambra, DP, Newby, D. Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021). EUROPEAN JOURNAL OF PUBLIC HEALTH. 2026; 36(2)DOI:10.1093/eurpub/ckaf153. PMID:41212072. IF:3.900(Q1/2D).
01/11/2024 Strategies for the prevention and non-pharmacological treatment of obesity. Models of care
Rosales, A, Mendoza, L, Minambres, I. Strategies for the prevention and non-pharmacological treatment of obesity. Models of care. Atencion Primaria. 2024; 56(11)DOI:10.1016/j.aprim.2024.102978. PMID:38820670. IF:1.600(Q2/4D).
01/08/2025 Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study
Blanco-Carrasco, AJ, Merino-Torres, JF, Almanza, MR, Molina, GC, Brito-Sanfiel, MA, Galindo, DEB, Olmedo, LAC, Mauricio, D, Povedano, ST, Barro, JAB, Sánchez, JJA, Mutiozabal, MS, Pimentel, B, Domínguez, AP, Arias-Cabrales, C, Fanjul, V, de Isla, LP, González, JFN. Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112214. PMID:40319920. IF:7.400(Q1/1D).
01/01/2026 Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study (vol 15, e95267, 2026)
Giné-Balcells, R, Vlacho, B, Vidal-Pérez, OC, Lecub, A, Franch-Nadal, J, Mauricio, D, Molló-Iniesta, A, Hernández, M. Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study (vol 15, e95267, 2026). Jmir Research Protocols. 2026; 15DOI:10.2196/95267. PMID:. IF:(Q/D).
18/11/2025 Deciphering the association between morphological differences in hypothalamic subregions and circulating ghrelin and leptin concentrations: exploratory evidence in anorexia nervosa and obesity
Collantoni, E, Miranda-Olivos, R, Ugur, S, Baenas, I, Tovar, S, Dieguez, C, Vilarrasa, N, Lopez-Urdiales, R, Guerrero-Pérez, F, Jiménez-Murcia, S, Soriano-Mas, C, Fernández-Aranda, F. Deciphering the association between morphological differences in hypothalamic subregions and circulating ghrelin and leptin concentrations: exploratory evidence in anorexia nervosa and obesity. Translational Psychiatry. 2025; 15(1)DOI:10.1038/s41398-025-03708-6. PMID:41253760. IF:6.200(Q1/1D).
01/01/2026 Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study
Giné-Balcells, R, Vlacho, B, Vidal-Pérez, OC, Lecube, A, Franch-Nadal, J, Mauricio, D, Molló-Iniesta, A, Hernández, M. Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study. Jmir Research Protocols. 2026; 15DOI:10.2196/85375. PMID:41734338. IF:(Q/D).
01/07/2025 Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study
Perea, V, Quirós, C, Herrera-Arranz, MT, Azriel-Mira, S, Wägner, AM, Beato-Vibora, P, Soldevila, B, Barquiel, B, Pardo, RM, Díaz-Soto, G, Picón, MJ, Colomo, N, Amigó, J, Climent, E, Durán-Martínez, M, Corcoy, R, Codina, M, Cuesta, M, Guedes, BV, Vinagre, I. Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study. ACTA DIABETOLOGICA. 2025; 62(7)DOI:10.1007/s00592-024-02430-x. PMID:39630235. IF:2.900(Q3/6D).
03/11/2025 HFpEF as the predominant and underrecognized heart failure phenotype in type 2 diabetes: evidence from the DIABET-IC study
Gil-Millan, P, Gimeno-Orna, JA, Rodriguez-Padial, L, Muniz, J, Barrios, V, Anguita, M, Perez, A. HFpEF as the predominant and underrecognized heart failure phenotype in type 2 diabetes: evidence from the DIABET-IC study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02995-z. PMID:41185008. IF:10.600(Q1/1D).